Skip to results
Modify your search
NARROW
1-20 of 23
Authors: Richard M. Goldberg
Sort by
Journal Article
Molecular Analyses of Left‐ and Right‐Sided Tumors in Adolescents and Young Adults with Colorectal Cancer
Mohamed E. Salem and others
The Oncologist, Volume 25, Issue 5, May 2020, Pages 404–413, https://doi.org/10.1634/theoncologist.2019-0552
Published: 17 December 2019
Journal Article
Impact of Patient Age on Molecular Alterations of Left‐Sided Colorectal Tumors
Alberto Puccini and others
The Oncologist, Volume 24, Issue 3, March 2019, Pages 319–326, https://doi.org/10.1634/theoncologist.2018-0117
Published: 17 July 2018
Journal Article
Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma
Mohamed E. Salem and others
The Oncologist, Volume 23, Issue 11, November 2018, Pages 1319–1327, https://doi.org/10.1634/theoncologist.2018-0143
Published: 04 June 2018
Journal Article
In Reply
Richard M. Goldberg and others
The Oncologist, Volume 23, Issue 1, January 2018, Page 136, https://doi.org/10.1634/theoncologist.2017-0542
Published: 13 November 2017
Journal Article
The Evolution of Clinical Trials in Oncology: Defining Who Benefits from New Drugs Using Innovative Study Designs
Richard M. Goldberg and others
The Oncologist, Volume 22, Issue 9, September 2017, Pages 1015–1019, https://doi.org/10.1634/theoncologist.2017-0153
Published: 15 June 2017
Journal Article
A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803
Donna Niedzwiecki and others
The Oncologist, Volume 22, Issue 1, January 2017, Pages 107–114, https://doi.org/10.1634/theoncologist.2016-0215
Published: 17 January 2017
Journal Article
Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance)
Preet Paul Singh and others
The Oncologist, Volume 21, Issue 12, December 2016, Pages 1509–1521, https://doi.org/10.1634/theoncologist.2016-0153
Published: 23 November 2016
Journal Article
In Memoriam: A Tribute to Daniel J. Sargent, Ph.D.
Richard M. Goldberg
The Oncologist, Volume 21, Issue 12, December 2016, Pages 1540–1541, https://doi.org/10.1634/theoncologist.2016-0425
Published: 07 November 2016
Journal Article
Genomic Profiling in Gastrointestinal Cancer: Are We Ready To Use These Data to Make Treatment Decisions?
Richard M. Goldberg
The Oncologist, Volume 20, Issue 12, December 2015, Pages 1448–1456, https://doi.org/10.1634/theoncologist.2015-0263
Published: 28 October 2015
Journal Article
FOLFIRINOX in Locally Advanced Pancreas Adenocarcinoma: Back to the Future?
Tanios Bekaii‐Saab and Richard M. Goldberg
The Oncologist, Volume 18, Issue 5, May 2013, Pages 487–489, https://doi.org/10.1634/theoncologist.2013-0157
Published: 15 April 2013
Journal Article
The ARCAD Clinical Trials Program: An Update and Invitation
Daniel J. Sargent and others
The Oncologist, Volume 17, Issue 2, February 2012, Pages 188–191, https://doi.org/10.1634/theoncologist.2011-0332
Published: 02 February 2012
Journal Article
KRAS and Colorectal Cancer: Ethical and Pragmatic Issues in Effecting Real‐Time Change in Oncology Clinical Trials and Practice
Charles D. Blanke and others
The Oncologist, Volume 16, Issue 8, August 2011, Pages 1061–1068, https://doi.org/10.1634/theoncologist.2011-0011
Published: 07 July 2011
Journal Article
Tumor Status at 12 Weeks Predicts Survival in Advanced Colorectal Cancer: Findings from NCCTG N9741
James M. Heun and others
The Oncologist, Volume 16, Issue 6, June 2011, Pages 859–867, https://doi.org/10.1634/theoncologist.2011-0064
Published: 31 May 2011
Journal Article
Scan? Cure? Sure!
Richard M. Goldberg and David P. Ryan
The Oncologist, Volume 16, Issue 2, February 2011, Pages 254–256, https://doi.org/10.1634/theoncologist.2011-0014
Published: 01 January 2011
Journal Article
A Cancer and Leukemia Group B Phase II Study of Sunitinib Malate in Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma (CALGB 80603)
Eileen M. O'Reilly and others
The Oncologist, Volume 15, Issue 12, December 2010, Pages 1310–1319, https://doi.org/10.1634/theoncologist.2010-0152
Published: 10 December 2010
Journal Article
NCCTG Study N9741: Leveraging Learning from an NCI Cooperative Group Phase III Trial
Richard M. Goldberg and others
The Oncologist, Volume 14, Issue 10, October 2009, Pages 970–978, https://doi.org/10.1634/theoncologist.2009-0175
Published: 14 October 2009
Journal Article
In Reply
Bert H. O’Neil and Richard M. Goldberg
The Oncologist, Volume 14, Issue 2, February 2009, Pages 194–196, https://doi.org/10.1634/theoncologist.2008-0291
Published: 16 January 2009
Journal Article
Commentary: Disclosure in Oncology—To Whom Does the Truth Belong?
William A. Wood and others
The Oncologist, Volume 14, Issue 1, January 2009, Pages 77–82, https://doi.org/10.1634/theoncologist.2008-0158
Published: 15 January 2009
Journal Article
Innovations in Chemotherapy for Metastatic Colorectal Cancer: An Update of Recent Clinical Trials
Bert H. O'Neil and Richard M. Goldberg
The Oncologist, Volume 13, Issue 10, October 2008, Pages 1074–1083, https://doi.org/10.1634/theoncologist.2008-0083
Published: 15 October 2008
Journal Article
Chemotherapy in Elderly Patients with Colorectal Cancer
Claus-Henning Köhne and others
The Oncologist, Volume 13, Issue 4, April 2008, Pages 390–402, https://doi.org/10.1634/theoncologist.2007-0043
Published: 01 April 2008
Advertisement
Advertisement